These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 12504058)
21. Limitations of the minimum peripheral dose as a parameter for dose specification in permanent 125I prostate implants. Yu Y; Waterman FM; Suntharalingam N; Schulsinger A Int J Radiat Oncol Biol Phys; 1996 Feb; 34(3):717-25. PubMed ID: 8621297 [TBL] [Abstract][Full Text] [Related]
22. An innovative dosimetric model for formulating a semi-analytical solution for the activity-volume relationship in prostate implants. Lee PC; Parks EK; Moran BJ Med Dosim; 2003; 28(4):243-53. PubMed ID: 14684189 [TBL] [Abstract][Full Text] [Related]
24. Loose versus stranded seeds in permanent prostate brachytherapy: dosimetric comparison of intraoperative plans. Major T; Agoston P; Fröhlich G; Baricza K; Szabo Z; Jorgo K; Herein A; Polgar C Phys Med; 2014 Dec; 30(8):909-13. PubMed ID: 25175151 [TBL] [Abstract][Full Text] [Related]
25. Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants. Chibani O; Williamson JF; Todor D Med Phys; 2005 Aug; 32(8):2557-66. PubMed ID: 16193786 [TBL] [Abstract][Full Text] [Related]
26. Dosimetric quality and evolution of edema after low-dose-rate brachytherapy for small prostates: implications for the use of newer isotopes. Kovtun KA; Wolfsberger L; Niedermayr T; Sugar EN; Graham PL; Murciano-Goroff Y; Beard C; D'Amico AV; Martin NE; Orio PF; Nguyen PL Brachytherapy; 2014; 13(2):152-6. PubMed ID: 23911279 [TBL] [Abstract][Full Text] [Related]
27. The impact of edema on planning 125I and 103Pd prostate implants. Yue N; Dicker AP; Nath R; Waterman FM Med Phys; 1999 May; 26(5):763-7. PubMed ID: 10360539 [TBL] [Abstract][Full Text] [Related]
28. New approach of ultra-focal brachytherapy for low- and intermediate-risk prostate cancer with custom-linked I-125 seeds: A feasibility study of optimal dose coverage. Brun T; Bachaud JM; Graff-Cailleaud P; Malavaud B; Portalez D; Popotte C; Aziza R; Lusque A; Filleron T; Ken S Brachytherapy; 2018; 17(3):544-555. PubMed ID: 29525514 [TBL] [Abstract][Full Text] [Related]
29. Analysis of the relationship between prescribed dose and dosimetric advantage of real-time intraoperatively built custom-linked seeds in iodine-125 prostate brachytherapy. Hirose K; Aoki M; Sato M; Akimoto H; Hashimoto Y; Imai A; Kamimura N; Kawaguchi H; Hatayama Y; Fujioka I; Tanaka M; Ohyama C; Takai Y Radiat Oncol; 2017 Dec; 12(1):192. PubMed ID: 29191234 [TBL] [Abstract][Full Text] [Related]
30. Influence of prostate volume on dosimetry results in real-time 125I seed implantation. McNeely LK; Stone NN; Presser J; Chircus JH; Stock RG Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):292-9. PubMed ID: 14697451 [TBL] [Abstract][Full Text] [Related]
31. Practical considerations in the selection of seed strength for prostate implants. Elliott SL; Beaufort CL; Millar JL J Appl Clin Med Phys; 2015 Sep; 16(5):53-61. PubMed ID: 26699289 [TBL] [Abstract][Full Text] [Related]
32. Is it necessary to eliminate the posterior dose margin in prostate brachytherapy to achieve an acceptably low risk of late rectal morbidity? Waterman FM; Dicker AP Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):293-9. PubMed ID: 12909246 [TBL] [Abstract][Full Text] [Related]
33. Dosimetric comparison between treatment plans of patients treated with low-dose-rate vs. high-dose-rate interstitial prostate brachytherapy as monotherapy: Initial findings of a randomized clinical trial. Major T; Polgár C; Jorgo K; Stelczer G; Ágoston P Brachytherapy; 2017; 16(3):608-615. PubMed ID: 28325472 [TBL] [Abstract][Full Text] [Related]
34. Robustness to source displacement in dual air kerma strength planning for focal low-dose-rate brachytherapy of prostate cancer. Mahdavi SS; Spadinger IT; Chng NT; Morris WJ Brachytherapy; 2016; 15(5):642-9. PubMed ID: 27263060 [TBL] [Abstract][Full Text] [Related]
36. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition. Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752 [TBL] [Abstract][Full Text] [Related]
37. Reducing seed waste and increasing value of dynamic intraoperative implantation of Pd-103 seeds in prostate brachytherapy. Taylor PK; Riegel AC J Appl Clin Med Phys; 2018 Sep; 19(5):383-388. PubMed ID: 30003681 [TBL] [Abstract][Full Text] [Related]
38. Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapy. Stone NN; Hong S; Lo YC; Howard V; Stock RG Brachytherapy; 2003; 2(1):17-25. PubMed ID: 15062159 [TBL] [Abstract][Full Text] [Related]